Other Terminations Clause Example from Business Contracts

This example Other Terminations clause appears in 11 contracts from 5 companies

Other Terminations. If Executive's employment with the Company terminates for any reason other than due to a Covered Termination, then Executive shall not be entitled to any benefits hereunder other than accrued but unpaid salary, vacation and expense reimbursements through the Termination Date in accordance with applicable law and to elect any continued healthcare coverage as may be required under COBRA or similar state law.
Found in Maxar Technologies Inc. contract
Satsuma Pharmaceuticals, Inc. Contracts

Form Change in Control and Severance Agreement (Filed With SEC on September 3, 2019)

Maxar Technologies Inc. Contracts

Form of Executive Change in Control and Severance Agreement (Filed With SEC on May 11, 2020)

Biomea Fusion, Inc. Contracts

Form Executive Change in Control and Severance Agreement (Filed With SEC on April 12, 2021)

Intuity Medical, Inc. Contracts

Change in Control and Severance Agreement, by and between Intuity Medical, Inc. and Emory Anderson (Filed With SEC on September 17, 2021)

Change in Control and Severance Agreement, by and between Intuity Medical, Inc. and Timothy Buskey (Filed With SEC on September 17, 2021)

Change in Control and Severance Agreement, by and between Intuity Medical, Inc. and Tammy Cameron (Filed With SEC on September 17, 2021)

Change in Control and Severance Agreement, by and between Intuity Medical, Inc. and Robb Hesley (Filed With SEC on September 17, 2021)

Change in Control and Severance Agreement, by and between Intuity Medical, Inc. and Dean Zikria (Filed With SEC on September 17, 2021)

4D Molecular Therapeutics Inc Contracts

Change in Control and Severance Agreement, dated September 22, 2021, by and between David Kirn and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)

Change in Control and Severance Agreement, dated September 22, 2021, by and between August Moretti and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)

Change in Control and Severance Agreement, dated September 22, 2021, by and between Robert Stephen Fishman and 4D Molecular Therapeutics, Inc (Filed With SEC on September 24, 2021)